Article
Combining a muscle-tropic AAV capsid with a muscle-specific promoter enhances skeletal muscle gene delivery while reducing off-target expression
2026-06-10
Abstract excerpt
<title>Abstract</title> <p> Objective Viral vector technologies based on adeno-associated viruses (AAV) have demonstrated promising ability to deliver genetic cargo to a range of organs <italic>in vivo</italic> , with several novel candidates showing clinical efficacy in human trials over the past decade. However, naturally occurring AAV serotypes are limited in their ability to target skeletal muscle, an imp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0e0b99ba-2bc8-5122-8be5-56f191343a05
- DOI
- 10.21203/rs.3.rs-9793637/v1
